1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

Tamper-Resistant PSE Takes Big Pharma Stage: Bayer Licenses Acura’s Formulation

 
• By Malcolm Spicer

Bayer gains exclusive worldwide license to Acura Pharmaceuticals’ Impede technology for use in a pseudoephedrine-containing product resistant to extraction to make methamphetamine. The deal is Acura’s first licensing, and the first move toward tamper-resistant PSE by a major pharma firm.

Bayer HealthCare LLCcould be the first big pharma firm to utter the “tamper resistant” tagline for nonprescription pseudoephedrine products as it licenses use of a formulation intended to prevent extraction of PSE to make methamphetamine.

Acura Pharmaceuticals Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America